SEARCH RESULTS FOR: "Tag: INSY"
REFINE YOUR SEARCH:
RECENT
Last Month(1)
ARTICLES/BLOGS
2019(1)
2018(4)
2017(2)
2016(4)
2015(1)
CATEGORIES
Analyst Downgrades(1)
Analyst Update(1)
Buzz Stocks(4)
Midday Market Check(3)
Opening View(1)
Stock Market News(1)
Stocks On the Move(2)

3/13/2019 2:46 PM
The Dow is on the mend today thanks to a Boeing (BA) bounce and upbeat economic data. Among stocks making notable moves today, orphan disease specialist Akari Therapeutics PLC (NASDAQ:AKTX) and can...
8/30/2018 12:04 PM
U.S. stocks are mostly lower today, though the Nasdaq Composite (IXIC) continues to flirt with positive territory after hitting another all-time high earlier. Investors are monitoring trade talks b...
8/30/2018 9:52 AM
Shares of Insys Therapeutics Inc (NASDAQ:INSY) are up 12.1% at $8.93 in early trading, after the Food and Drug Administration (FDA) granted the company's epinephrine nasal spray for anaphylaxis "Fas...
3/19/2018 10:11 AM
Cidara Therapeutics Inc (NASDAQ:CDTX) stock is lower today, down 22% to trade at $6.09, despite the biotech company reporting its anti-fungal drug Rezafungin acetate met the main goals of a mid-stage ...
1/3/2018 12:07 PM
The U.S. stock market is pushing further into record-high territory today, despite some alarming tweets overnight from President Donald Trump. The Dow Jones Industrial Average (DJIA), S&P 500 Ind...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center